Atrys Health, S.A. is a Spain-based biomedical company specializing in precision diagnostic services and oncology treatments. Founded in 2007 and headquartered in Madrid, it operates through segments including Diagnosis, Oncology, and Preventive Medicine, delivering integrated solutions like structural and molecular pathology, genetics, nuclear medicine, telemedicine in radiology, cardiology, ophthalmology, dermatology, and advanced therapies such as chemotherapy, immunotherapy, radiotherapy, and brachytherapy. With over 2,200 professionals across eight countries, including Spain, Portugal, and Latin America, Atrys Health emphasizes a 360-degree approach from prevention to cancer treatment, leveraging technology for telediagnosis and personalized care. The company, formerly Althia Health, pioneered telemedicine and radiotherapy innovations, integrating 14 acquisitions since 2018 for robust growth in laboratory testing, tele-diagnostics, and corporate health plans. Classified in the healthcare sector's biotechnology industry, it supports hospitals, insurers, and businesses with research-driven services.